Statistics for West Pharmaceutical Services (id:8673 WST)

Valuation metrics

Market cap

22.57B

Enterprise value

21.84B

Trailing P/E (ttm)

46.17

Forward P/E

41.44

PEG ratio

41.44

Price/Sales (ttm)

7.85

Price/Book (mrq)

8.21

Enterprise Value/Revenue

7.59

Enterprise Value/EBITDA

29.33

Overview

Shares outstanding

72.42M

Float

71.94M

Shares short

1.43M

% Held by insiders

0.01%

% Held by institutions

0.97%

Average volume (10 days)

642.11K

Average volume (90 days)

Price summary

52-Week low

265.00

52-Week high

413.70

52-Week change

-13.35%

Beta

1.00

50-Day moving average

306.04

200-Day moving average

334.65

Dividends and splits

Forward annual dividend rate

0.84

Forward annual dividend yield

0.00

Trailing annual dividend rate

0.80%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

0.24

Payout ratio

0.12

Dividend date

November 20th, 2024

Ex-dividend date

November 13th, 2024

Last split factor

2:1

Last split date

September 27th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

17.37%

Operating margin

22.32%

Operational effectiveness

Return on assets

10.00%

Return on equity

17.78%

Income statement

Revenue (ttm)

39.23

Revenue per share (ttm)

39.23

Quarterly revenue growth (yoy)

-0.16

Gross profit (ttm)

1.13B

EBITDA

763.00M

Net income to common (ttm)

499.60M

Diluted EPS (ttm)

6.75

Quarterly earnings growth (yoy)

-15.70%

Balance sheet

Total cash (mrq)

490.90M

Total cash per share (mrq)

6.78

Total debt (mrq)

307.90M

Total Debt/Equity (mrq)

11.19

Current ratio (mrq)

300.20%

Book value per share (mrq)

37.96

Cash flow

Cash flow statement

702.40M

Levered free cash flow (LFCF)

201.69M